James Campling

639 total citations
20 papers, 196 citations indexed

About

James Campling is a scholar working on Epidemiology, Emergency Medicine and Health. According to data from OpenAlex, James Campling has authored 20 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Emergency Medicine and 2 papers in Health. Recurrent topics in James Campling's work include Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (10 papers) and Emergency and Acute Care Studies (8 papers). James Campling is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (10 papers) and Emergency and Acute Care Studies (8 papers). James Campling collaborates with scholars based in United Kingdom, United States and Australia. James Campling's co-authors include Harish Madhava, James D. Chalmers, Gillian Ellsbury, Andrew Vyse, Mary Slack, Mark Woodhead, Alison Dicker, Diana Mendes, Tendai Mugwagwa and Dylan Jones and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Vaccine.

In The Last Decade

James Campling

19 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Campling United Kingdom	8	177	41	27	23	13	20	196
Priya Daniel United Kingdom	8	220 1.2×	53 1.3×	41 1.5×	17 0.7×	21 1.6×	13	252
Gillian Ellsbury United Kingdom	7	122 0.7×	30 0.7×	26 1.0×	12 0.5×	11 0.8×	19	141
Sonia Greenwood United Kingdom	8	311 1.8×	25 0.6×	74 2.7×	21 0.9×	21 1.6×	10	327
Bart Adriaan van der Beek Israel	7	218 1.2×	21 0.5×	54 2.0×	33 1.4×	39 3.0×	14	244
Gertjan H.J. Wagenvoort Netherlands	7	171 1.0×	21 0.5×	59 2.2×	5 0.2×	22 1.7×	13	190
Leilani T Nillos Philippines	4	188 1.1×	17 0.4×	57 2.1×	15 0.7×	9 0.7×	5	213
Angelique G.S.C. Jansen Netherlands	6	289 1.6×	24 0.6×	89 3.3×	17 0.7×	42 3.2×	7	310
Christopher J. Babbitt United States	4	162 0.9×	20 0.5×	14 0.5×	53 2.3×	33 2.5×	4	197
Mélina Messaoudi France	6	149 0.8×	10 0.2×	33 1.2×	33 1.4×	16 1.2×	11	180
Casey L. Pell Australia	7	239 1.4×	13 0.3×	80 3.0×	13 0.6×	11 0.8×	18	257

Countries citing papers authored by James Campling

Since Specialization

Citations

This map shows the geographic impact of James Campling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Campling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Campling more than expected).

Fields of papers citing papers by James Campling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Campling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Campling. The network helps show where James Campling may publish in the future.

Co-authorship network of co-authors of James Campling

This figure shows the co-authorship network connecting the top 25 collaborators of James Campling. A scholar is included among the top collaborators of James Campling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Campling. James Campling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cleary, David, James Campling, María Lahuerta, et al.. (2024). Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK. Microbiology Spectrum. 12(8). e0022424–e0022424. 2 indexed citations

Reynard, Charles, James Campling, Adam Gordon, et al.. (2024). Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment. Expert Review of Vaccines. 23(1). 1052–1067. 1 indexed citations

Hyams, Catherine, María Lahuerta, Christian Theilacker, et al.. (2024). Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK. Vaccine. 42(7). 1599–1607. 4 indexed citations

Mendes, Diana, Mark Atwood, Reiko Sato, et al.. (2023). OP78 Cost-effectiveness Of A 20-valent Pneumococcal Conjugate Vaccine To Directly Protect Adults Against Pneumococcal Disease In England. International Journal of Technology Assessment in Health Care. 39(S1). S20–S21.

Campling, James, Andrew Vyse, Mary Slack, et al.. (2023). A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom. Expert Review of Vaccines. 22(1). 785–800. 16 indexed citations

Hyams, Catherine, Elizabeth Begier, María García González, et al.. (2022). Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology. BMJ Open. 12(6). e057464–e057464. 8 indexed citations

Campling, James, Elizabeth Begier, Andrew Vyse, et al.. (2022). A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England. Epidemiology and Infection. 150. e150–e150. 2 indexed citations

Campling, James, Gillian C. Hall, Tendai Mugwagwa, et al.. (2022). Hospitalization costs of adult community-acquired pneumonia in England. Journal of Medical Economics. 25(1). 912–918. 15 indexed citations

Mendes, Diana, Mark Atwood, Reiko Sato, et al.. (2022). Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease. Expert Review of Pharmacoeconomics & Outcomes Research. 22(8). 1285–1295. 23 indexed citations

10.

Mugwagwa, Tendai, Mark Atwood, Reiko Sato, et al.. (2022). Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert Review of Vaccines. 21(9). 1331–1341. 4 indexed citations

11.

Vyse, Andrew, James Campling, Carole Czudek, et al.. (2021). A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK. Expert Review of Vaccines. 20(10). 1311–1325. 6 indexed citations

12.

Campling, James, Elizabeth Begier, Andrew Vyse, et al.. (2021). A novel approach to calculate disease incidence for hospital-based health events in England. The Lancet. 398. S30–S30. 1 indexed citations

13.

Ellsbury, Gillian, James Campling, Harish Madhava, & Mary Slack. (2021). Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm. Journal of Travel Medicine. 28(6). 1 indexed citations

14.

Campling, James, et al.. (2020). Co‐diagnoses of acute myeloid leukaemia and COVID‐19: presentation and management implications. Respirology Case Reports. 8(7). e00650–e00650. 4 indexed citations

15.

Vyse, Andrew, James Campling, Carole Czudek, Gillian Ellsbury, & Mary Slack. (2020). The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development. Vaccine. 38(51). 8068–8070. 4 indexed citations

16.

Campling, James, Dylan Jones, James D. Chalmers, et al.. (2020). Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England. BMJ Open Respiratory Research. 7(1). e000703–e000703. 16 indexed citations

17.

Campling, James, Dylan Jones, James D. Chalmers, et al.. (2019). The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in England. SHILAP Revista de lepidopterología. 11(1). 4–4. 19 indexed citations

18.

Campling, James, Dylan Jones, Gillian Ellsbury, et al.. (2017). S6 Establishing the true incidence of hospitalised community acquired pneumonia (cap) in the uk: a hospital episode statistics (hes) analysis. HighWire Press Open Archive. A7–A7. 1 indexed citations

19.

Chalmers, James D., James Campling, Alison Dicker, Mark Woodhead, & Harish Madhava. (2016). A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults. BMC Pulmonary Medicine. 16(1). 77–77. 60 indexed citations

20.

Verma, Anita, Georg Auzinger, Michal Kantecki, et al.. (2016). Safety and Efficacy of Anidulafungin for Fungal Infection in Patients With Liver Dysfunction or Multiorgan Failure. Open Forum Infectious Diseases. 4(1). ofw241–ofw241. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact